LAT
Research is a privately-owned full-service CRO company which operates in Latin
American countries with staff dedicated to all aspects of Regulatory Affairs,
Strategic Planning, Clinical Research, Medical Writing, Biostatistics and
Pharmacovigilance. LAT was created in 2010 to conduct the first full-scale
clinical trial in the setting of Chagas Disease in pediatric population. Since
then, our staff have been involved in 50 different studies, 26 of them fully
conducted enrolling more than 6,600 patients in different therapeutic areas. Particularly
in neglected diseases, LAT is the more experienced organization in conducting
clinical trials in LATAM. Solid experience in helping companies to reach the
goals for priority review vouchers in neglected or tropical diseases, rare
disease or pediatric indications based on qualified staff and access to target
population.
AR
